Cell cycle- and activation-dependent regulation of cyclosporin A-induced T cell apoptosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2003-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2003.08.141PMID 14521916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inducible p27Kip1 expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors

  2003cited by this paper
• The role of CD95 in the regulation of peripheral T‐cell apoptosis

  2003cited by this paper
• Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells.

  2002cited by this paper
• The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

  2002cited by this paper
• On the Role of Proteasomes in Cell Biology and Proteasome Inhibition as a Novel Frontier in the Development of Immunosuppressants

  2002cited by this paper
• Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.

  2002cited by this paper
• Mechanisms of caspase activation and inhibition during apoptosis.

  2002cited by this paper
• Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs

  2002cited by this paper
• Role and Function of the 26S Proteasome in Proliferation and Apoptosis

  2002cited by this paper
• A proteasome inhibitor effectively prevents mouse heart allograft rejection.

  2001cited by this paper
• Cyclosporine and long-term kidney graft survival.

  2001cited by this paper
• The biochemistry of apoptosis

  2000cited by this paper
• Calcineurin: form and function.

  2000cited by this paper
• Mechanisms of action of cyclosporine.

  2000cited by this paper
• A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation.

  2000cited by this paper
• Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.

  2000cited by this paper
• Proteasome inhibitors induce caspase‐dependent apoptosis and accumulationof p21WAF1/Cip1 in human immatureleukemic cells

  2000cited by this paper
• Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.

  1999cited by this paper
• Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

  1999cited by this paper
• Tumor Necrosis Factor-α and Interferon-γ Induce Expression of Functional Fas Ligand on HT29 and MCF7 Adenocarcinoma Cells

  1999cited by this paper
• Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

  1999cited by this paper
• In vitro and in vivo correlation of cyclosporin A‐induced apoptosis in acute lymphoblastic leukemia

  1999cited by this paper
• Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells.

  1999cited by this paper
• CD69 and regulation of the immune function.

  1999cited by this paper
• Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells.

  1998cited by this paper
• Role of proteasomes in T cell activation and proliferation.

  1998cited by this paper
• Cyclosporin A Induces Apoptosis in Childhood Acute Lymphoblastic Leukemia Cells

  1998cited by this paper
• Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression

  1998cited by this paper
• A regulatory element in the CD95 (APO‐1/Fas) ligand promoter is essential for responsiveness to TCR‐mediated activation

  1998cited by this paper
• Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.

  1998cited by this paper
• Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin in Cultured Cells*

  1997cited by this paper
• p27Kip1 overexpression causes apoptotic death of mammalian cells

  1997cited by this paper
• Proteasome regulation of activation-induced T cell death.

  1997cited by this paper
• Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.

  1997cited by this paper
• Processing/Activation of At Least Four Interleukin-1β Converting Enzyme–like Proteases Occurs during the Execution Phase of Apoptosis in Human Monocytic Tumor Cells

  1997cited by this paper
• Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation

  1997cited by this paper
• Transcription factors of the NFAT family: regulation and function.

  1997cited by this paper
• Two NFAT Transcription Factor Binding Sites Participate in the Regulation of CD95 (Fas) Ligand Expression in Activated Human T Cells*

  1997cited by this paper
• Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

  1996cited by this paper
• Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.

  1996cited by this paper
• Translational Control of p27Kip1 Accumulation During the Cell Cycle

  1996cited by this paper
• Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

  1995cited by this paper
• Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

  1995cited by this paper
• lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin

  1994cited by this paper
• Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

  1993cited by this paper
• Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

  1993cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper

• Proteostasis in T cell aging

  2023cites this paper
• Effects of cyclosporine on feline lymphocytes activated in vitro.

  2019cites this paper
• Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence

  2019cites this paper
• Biological effects of cyclosporin A on CD3−CD161+ and CD3+CD161+ lymphocytes

  2019cites this paper
• Apoptosis of T Cells and Monocytes

  2015cites this paper
• Proteasome inhibitors as experimental therapeutics of autoimmune diseases

  2015cites this paper
• Modulation of Proteasome Pathways by Nutraceuticals

  2013cites this paper
• Molecular events associated with ciclosporin A-induced gingival overgrowth are attenuated by Smad7 overexpression in fibroblasts.

  2012cites this paper
• Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice

  2012cites this paper
• Preliminary study to characterize differences in potential immunomodulatory effects of cyclosporine A using BALB / c and ICR mouse splenocytes

  2011cites this paper
• Preliminary study to characterize differences in potential immunomodulatory effects of cyclosporine A using BALB/c and ICR mouse splenocytes

  2011cites this paper
• In vitro and in vivo immunomodulatory effects of cobalt protoporphyrin administered in combination with immunosuppressive drugs.

  2010cites this paper
• Bortezomib: a promising treatment for inflammatory diseases

  2010cites this paper
• The proteasome inhibitor bortezomib inhibits T cell‐dependent inflammatory responses

  2010cites this paper
• Helenalin suppresses essential immune functions of activated CD4+ T cells by multiple mechanisms.

  2009cites this paper
• Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells

  2008cites this paper
• Proteasome inhibition suppresses essential immune functions of human CD4+ T cells

  2008cites this paper
• Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition.

  2007cites this paper
• Proteasomal chymotrypsin‐like peptidase activity is required for essential functions of human monocyte‐derived dendritic cells

  2007cites this paper
• Apoptosis as a Therapeutic Tool in IBD?

  2006cites this paper
• Immunomodulatory role of native and heat denatured agglutinin from Abrus precatorius.

  2005cites this paper
• Calcium ionophoretic and apoptotic effects of ferutinin in the human Jurkat T-cell line.

  2004cites this paper